Osteopenia Clinical Trial
Official title:
Reliability and Validity Study of the Facilitators and Barriers Exercise Questionnaire
The PEQ is the first tool to measure facilitators, barriers, and preferences to exercise in people with osteoporosis.
Osteoporosis is a disease of the bones characterized by low bone mass and microarchitectural
deterioration of bone tissue. This disease can increase the risk of bone fragility fractures
and is indirectly associated with premature death. These fractures are more common than
cancer or heart disease in North American women 50 years or older, with an osteoporotic
fracture occurring every 3 seconds worldwide, and are a major issue to patients and the
healthcare system. Increased fracture rates, particularly in the hip and spine, may lead to
hospitalization and subsequent immobility.
Some studies have shown fitness to be a better predictor of bone mineral density than age,
yet adherence to exercise is poor. Studies suggest that 50% of those registered in an
exercise program drop out within the first 6 months, lack of time being the number one
barrier in many populations. To increase adherence to an exercise program, a systematic
review has identified a number of facilitators and barriers to exercise in adults with
osteoporosis and osteopenia.
Hitherto, no measurement tool has been created to measure these facilitators and barriers in
people with osteoporosis. The investigators have developed and validated the PEQ
(Personalized Exercise Questionnaire), a new tool that can measure the facilitators,
barriers, and preferences to exercise. The next steps are to test the reliability,
known-group validity, and pilot test this tool in the osteoporosis population.
Future physical activity or exercise interventions could benefit from using this tool to
leveraging the facilitators and limiting the barriers to exercise to increase adherence to an
exercise program.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Active, not recruiting |
NCT05066477 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Bone Mass Among Osteopenic Women
|
N/A | |
Terminated |
NCT01902186 -
Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
|
Phase 4 | |
Completed |
NCT01439139 -
Bone UltraSonic Scanner (BUSS): Validation Study
|
N/A | |
Not yet recruiting |
NCT01397838 -
Safety Study of an Oral Pro-boneTM, Administered to Post Menopausal Osteopenic Women
|
Phase 1 | |
Completed |
NCT01222026 -
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
|
Phase 4 | |
Completed |
NCT01152580 -
Melatonin Osteoporosis Prevention Study
|
Phase 1 | |
Completed |
NCT00789425 -
Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal Women
|
Phase 2 | |
Completed |
NCT00463268 -
Osteoporosis Prevention With Low Dose Alendronate
|
Phase 3 | |
Completed |
NCT00655681 -
Prevention of Post Operative Bone Loss in Children
|
N/A | |
Completed |
NCT00798473 -
Zoledronate for Osteopenia in Pediatric Crohn's
|
Phase 3 | |
Active, not recruiting |
NCT00076050 -
Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms
|
Phase 3 | |
Completed |
NCT00226031 -
Optimal Management of Women With Wrist Fractures
|
N/A | |
Enrolling by invitation |
NCT04752098 -
A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method
|
N/A | |
Completed |
NCT04720833 -
Effect of Dried Plum on Bone and Markers of Bone Status in Men
|
N/A | |
Recruiting |
NCT05541432 -
Finding the Optimal Resistance Training Intensity For Your Bones
|
N/A | |
Active, not recruiting |
NCT05405894 -
Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
|
||
Completed |
NCT05457036 -
Evaluation of the Effect of Spry Belt Treatment on Bone Turnover Marker Profile
|
N/A | |
Completed |
NCT04040010 -
The Effects of Bovine Colostrum in Bone Metabolism in Humans
|
N/A | |
Completed |
NCT02731820 -
Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia
|
N/A |